Notably, tirzepatide-treated patients experienced substantial weight loss (7.5 kg with 5 mg, 10.7 kg with 10 mg, and 12.9 kg with 15 mg), whilst those receiving insulin gained an average of 2.3 kga clinically important distinction for patients with type 2 diabetes who often struggle with weight management
Minimals weight loss program prominently features a GLP-1 receptor agonist, specifically semaglutide, which is known for its effectiveness in reducing appetite and enhancing metabolic function
Raal, F
So lets talk about whats actually behind the trend, and how GLP-1 medications like Ozempic, Wegovy, and Zepbound can support fertility when used with intention and medical guidance
Clinically prescribed, no insurance needed
Budget/Insurance: Semaglutide is often more widely covered by insurance or available at a lower price point in compounded forms